Analyst Price Targets — EVO
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| July 15, 2026 9:58 am | Swayampakula Ramakanth | H.C. Wainwright | $4.00 | $2.14 | TheFly | Evotec price target lowered to $4 from $7 at H.C. Wainwright |
| July 15, 2026 6:51 am | — | Macquarie | $2.00 | $2.14 | StreetInsider | TD Cowen Downgrades Evotec (EVO) to Hold |
| August 14, 2025 10:04 am | Douglas Tsao | H.C. Wainwright | $7.00 | $3.81 | TheFly | Evotec price target lowered to $7 from $8 at H.C. Wainwright |
| August 15, 2024 6:39 am | Douglas Tsao | H.C. Wainwright | $8.00 | $3.22 | StreetInsider | Evotec (EVO) PT Lowered to $8 at H.C. Wainwright |
| April 25, 2024 6:39 am | Douglas Tsao | H.C. Wainwright | $11.00 | $5.23 | StreetInsider | Evotec (EVO) PT Lowered to $11 at H.C. Wainwright |
| December 9, 2022 6:39 am | — | H.C. Wainwright | $12.00 | $8.38 | Benzinga | HC Wainwright & Co. Initiates Coverage On Evotec with Buy Rating, Announces Price Target of $12 |
Latest News for EVO
Evotec Appoints Dr. Joanna Holbrook as Chief Scientific Officer and Member of the Management BoardPR NewswireHAMBURG, Germany, Oct. 15, 2026Will lead Evotec's g
Will lead Evotec's global scientific strategy and drive differentiation across its discovery and development services, technology platforms and proprietary innovation Brings more than 25 years of global experience in pharma, biotechnology and academia HAMBURG, Germany, Oct. 15, 2026 /PRNewswire/ -- Evotec SE (NASDAQ: EVO) (Frankfurt Prime Standard: EVT) today announced the appointment of Dr. Joanna Holbrook as Chief…
Evotec AG (NASDAQ: EVO - Get Free Report) saw unusually-strong trading volume on Monday. 143,696 shares traded hands during mid-day trading, an increase of 43% from the previous session's volume of 100,289 shares. The stock last traded at $1.5810 and had previously closed at $1.56. Analyst Ratings Changes A number of research analysts have recently commented
Evotec Announces Chief Scientific Officer TransitionPR NewswireHAMBURG, Germany, Sept. 29, 2026Dr. Cord Dohrmann to step down as of September 30, 2026Search ong
Dr. Cord Dohrmann to step down as of September 30, 2026 Search ongoing for a successor HAMBURG, Germany, Sept. 29, 2026 /PRNewswire/ -- Evotec SE (NASDAQ: EVO) (Frankfurt Prime Standard: EVT) today announced that Chief Scientific Officer (CSO) Dr. Cord Dohrmann will step down effective September 30, 2026.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for EVO.
U.S. House Trading
No House trades found for EVO.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.